![Nessan Bermingham](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 470 879 $ al 31/05/2026
Nessan Bermingham founded Tal Medical, Inc. in 2011, where he worked as Chief Executive Officer, Bio Equity Capital LLC in 2009, where he worked as Managing Partner from 2009 to 2018, Intellia Therapeutics, Inc. in 2014, where he worked as President, Chief Executive Officer & Director from 2014 to 2017, and various other companies.
Dr. Bermingham also founded Serentis Ltd., Korro Bio, Inc. (United States), where he is working as Executive Chairman, and Liberate Bio, Inc., where he is working as President, Treasurer, Secretary & Director.
Dr. Bermingham also currently works at F-star Biotechnology Ltd., as Chairman, F-star Therapeutics Ltd., as Chairman from 2018, Deep Genomics, Inc., as Director from 2023, and various other companies.
Dr. Bermingham also formerly worked at EveryONE Medicines, Inc., as Chief Executive Officer from 2022 to 2024, F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH, as Executive Chairman from 2018 to 2019, Xilio Therapeutics, Inc., as Executive Chairman from 2018 to 2020, and various other companies.
Dr. Bermingham received his doctorate degree from Imperial College London and undergraduate degree from Queen's University Belfast A.F.C.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
0,24 % | 10/06/2026 | 35.114 ( 0,24 % ) | 470 879 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
Baylor College of Medicine
 Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
F-star Biotechnology Ltd.
 F-star Biotechnology Ltd. BiotechnologyHealth Technology Operates as a biotechnology company | Presidente | - |
Khosla Ventures LLC
 Khosla Ventures LLC Investment ManagersFinance Khosla Ventures invests in companies located in the United States with transaction size that exceed USD 10 million. The firm targets companies operating across a broad range of sectors and industries. It participates in seed, early and later stage capital requirements with an revenue ranging from USD 50 to 150 million. | Inversor de Capital Privado | 01/12/2021 |
Charm Therapeutics Ltd.
 Charm Therapeutics Ltd. BiotechnologyHealth Technology Engages in research and development on biotechnology | Director/Miembro de la Junta | - |
Deep Genomics, Inc.
 Deep Genomics, Inc. BiotechnologyHealth Technology Provides machine learning, genome biology and precision medicine | Director/Miembro de la Junta | 06/01/2023 |
Liberate Bio, Inc.
 Liberate Bio, Inc. BiotechnologyHealth Technology Develops novel genetic medicines | Fundador | - |
Korro Bio, Inc.
 Korro Bio, Inc. BiotechnologyHealth Technology Develops novel genetic medicines | Fundador | - |
F-star Therapeutics Ltd.
 F-star Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops antibodies therapeutics for cancer therapy | Presidente | 10/09/2018 |
| Empresas | Cargo | Fin |
|---|---|---|
EveryONE Medicines, Inc.
 EveryONE Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Develops precision therapeutics | Director Ejecutivo | 10/07/2024 |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | ░░░░░░░░░░ |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 35 |
|---|---|
LAB International, Inc.
 LAB International, Inc. Pharmaceuticals: MajorHealth Technology Develops, researches and discovers generic therapeutics | Health Technology |
Cellzome Ltd.
 Cellzome Ltd. Pharmaceuticals: MajorHealth Technology Discovers and manufactures drugs | Health Technology |
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH
 F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies and antibody fragments for cancer | Health Technology |
Omega Funds
 Omega Funds Investment Trusts/Mutual FundsMiscellaneous Open-End Investment Fund/Unit Trust | Miscellaneous |
Tal Medical, Inc.
 Tal Medical, Inc. Medical SpecialtiesHealth Technology Operates as a clinical stage medical device company | Health Technology |
Navitor Pharmaceuticals, Inc.
 Navitor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops targeted therapeutics | Health Technology |
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arrow Therapeutics Ltd.
 Arrow Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
NsGene A/S
 NsGene A/S Pharmaceuticals: MajorHealth Technology Provides therapeutic products for the treatment of neurodegenerative disorders | Health Technology |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PreciSense A/S
 PreciSense A/S Electronic Equipment/InstrumentsElectronic Technology Develops and distributes non-invasive blood glucose monitoring systems | Electronic Technology |
Khosla Ventures LLC
Khosla Ventures LLC Investment ManagersFinance Khosla Ventures invests in companies located in the United States with transaction size that exceed USD 10 million. The firm targets companies operating across a broad range of sectors and industries. It participates in seed, early and later stage capital requirements with an revenue ranging from USD 50 to 150 million. | Finance |
Serentis Ltd.
 Serentis Ltd. Pharmaceuticals: MajorHealth Technology Discovers, develops and distributes pharmaceutical products | Health Technology |
Renovo Services LLC
 Renovo Services LLC Miscellaneous Commercial ServicesCommercial Services Provides repossession services | Commercial Services |
UBS Warburg, Inc. | |
Bio Equity Capital LLC
 Bio Equity Capital LLC Investment ManagersFinance Bio Equity Capital invests in middle market companies located in the United States. The firm focuses on a broad range of sectors and industries. It participates in early stage capital transactions with an investment size of more than USD 1 million. The firm makes follow-on investments. | Finance |
F-Star Therapeutics, Inc. (United States)
 F-Star Therapeutics, Inc. (United States) Pharmaceuticals: MajorHealth Technology Engages in discovery, development and preparation of bioavailable therapeutics | Health Technology |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
F-star Alpha Ltd.
 F-star Alpha Ltd. BiotechnologyHealth Technology Develops novel bispecific antibody products | Health Technology |
F-star Biotechnology Ltd.
F-star Biotechnology Ltd. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Intellia Therapeutics, Inc.
 Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics | Health Technology |
Deep Genomics, Inc.
Deep Genomics, Inc. BiotechnologyHealth Technology Provides machine learning, genome biology and precision medicine | Health Technology |
Xilio Therapeutics, Inc.
 Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies | Health Technology |
F-Star Beta Ltd.
 F-Star Beta Ltd. BiotechnologyHealth Technology Researches and develops oncology and immuno-oncology compounds | Health Technology |
Triplet Therapeutics, Inc.
 Triplet Therapeutics, Inc. Medical/Nursing ServicesHealth Services Develops therapy for huntington's , myotonic dystrophy, spin cerebellar ataxias and repeated expansion diseases | Health Services |
Korro Bio, Inc.
Korro Bio, Inc. BiotechnologyHealth Technology Develops novel genetic medicines | Health Technology |
F-Star Delta Ltd.
 F-Star Delta Ltd. Pharmaceuticals: MajorHealth Technology Develops antibody products to improve the treatment of serious diseases | Health Technology |
Queen's University Belfast A.F.C.
 Queen's University Belfast A.F.C. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
F-star Therapeutics Ltd.
F-star Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops antibodies therapeutics for cancer therapy | Health Technology |
F-star Therapeutics, Inc.
 F-star Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops antibody therapeutics for cancer and other diseases | Health Technology |
EveryONE Medicines, Inc.
EveryONE Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Develops precision therapeutics | Commercial Services |
Charm Therapeutics Ltd.
Charm Therapeutics Ltd. BiotechnologyHealth Technology Engages in research and development on biotechnology | Health Technology |
Liberate Bio, Inc.
Liberate Bio, Inc. BiotechnologyHealth Technology Develops novel genetic medicines | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
